Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Disease Areas
  • Other Medical News
  • Podcast
  • Videos
  • Education
  • About
    • Vacancies

Tag: SARS-CoV-2

‘No’ to routine use of rivaroxaban in outpatients with COVID-19

Presented By
Dr Gregory Piazza, Brigham and Women’s Hospital, MA, USA
Trial
PREVENT-HD
Conference
AHA 2022

11 January, 2023 12:21

COVID-19 pandemic: Older adults and those affected by the delta variant experienced increased cardiovascular morbidity and mortality

Presented By
Dr Pratyaksh Srivastava, Cedars-Sinai Medical Center, CA
Conference
AHA 2022

11 January, 2023 10:01

COVID-19 mRNA vaccination does not amplify risk of cardiovascular hospitalisation

Presented By
Dr Anthony Simone, Kaiser Permanente Los Angeles Medical Center, USA
Conference
AHA 2022

11 January, 2023 09:57

Humoral and cellular immune responses after SARS-CoV-2 vaccination

Presented By
Dr Monika Rabenstein, Karolinska Institute, Sweden
Conference
ECTRIMS 2022

20 December, 2022 11:42

SARS-CoV-2: Booster doses of key importance for cirrhotic patients

Presented By
Dr Samer Al-Dury, Sahlgrenska University Hospital, Sweden
Conference
UEGW 2022

2 December, 2022 09:11

Lack of vaccination results in a higher frequency of pre-term births in pregnant women with rheumatic disease and COVID-19

Presented By
Dr Sinead Magui, St. James’ Hospital, Ireland
Conference
ACR 2022

1 December, 2022 14:12

Damaged skin as a possible transmission route for SARS-CoV-2

Presented By
Dr Hanan Osman-Ponchet
Conference
EADV 2021

18 November, 2021 13:24

No increased risk of (severe) COVID-19 among IBD patients

Presented By
Dr Vered Richter , Tel Aviv University, Israel
Conference
ECCO 2021

2 July, 2021 23:52

COVID-19 in patients with rheumatic disease: most report mild disease

Presented By
Dr Akhil Sood, University of Texas Medical Branch, USA
Conference
ACR 2020

18 January, 2021 10:57

Poor disease control: a risk factor for severe COVID-19

Presented By
Prof. Rebecca Grainger, University of Otago, New Zealand
Trial
COVID-19 Global Rheumatology Alliance Registry
Conference
ACR 2020

18 January, 2021 10:57

No heightened outcome risk for rheumatic patients with COVID-19

Presented By
Dr Naomi Serling-Boyd, Massachusetts General Hospital, USA
Conference
ACR 2020

18 January, 2021 10:56

Insufficient antimalarial supply for rheumatic disease treatment in the early COVID-19 pandemic

Presented By
Ms Emily Sirotich, COVID‐19 Global Rheumatology Alliance Steering Committee and McMaster University, Canada
Conference
ACR 2020

18 January, 2021 10:38

Biologic psoriasis treatment and COVID-19 risk: Contradictory results

Presented By
Dr Anne-Claire Fougerousse; Dr Giovanni Damiani
Conference
EADV 2020

17 December, 2020 14:12

Much to be learned about COVID-19 and the skin

Presented By
Prof. Esther Freeman, Director of the COVID-19 Dermatology Registry
Trial
COVID-19 Dermatology Registry
Conference
EADV 2020

17 December, 2020 14:00

COVID-19: Continuing versus suspending ACE inhibitors and ARBs

Presented By
Prof. Renato Lopes, Duke University, USA
Trial
Phase 4, BRACE CORONA trial
Conference
ESC 2020

5 November, 2020 13:10

Risk factors for thromboembolism and bleeding in COVID-19: lessons from Wuhan

Presented By
Prof. Yutao Guo , Chinese PLA General Hospital, China
Conference
ESC 2020

5 November, 2020 12:27

The Yale COVID-19 Cardiovascular Registry

Presented By
Dr Manan Pareek, Yale University School of Medicine, USA
Trial
Yale COVID-19 Cardiovascular Registry
Conference
ESC 2020

5 November, 2020 12:24

COVID-19 treatments and the importance of randomised trials

Presented By
Prof. Martin Landray, University of Oxford, UK
Trial
RECOVERY
Conference
ESC 2020

5 November, 2020 11:49

COVID-19 infections: Bronchoscopy provides additional diagnostic certainty

Presented By
Dr Thomas Malfait, Ghent University Hospital, Belgium
Conference
ERS 2020

29 October, 2020 20:11

COVID-19 vaccines: An ongoing race

Presented By
Prof. George Karakiulakis, Aristotle University of Thessaloniki, Greece
Conference
ERS 2020

29 October, 2020 20:08

COVID-19: What is the risk of reinfection?

Presented By
Prof. Peter Openshaw, Imperial College of London, UK
Trial
ISARIC-4C
Conference
ERS 2020

29 October, 2020 20:01

COVID-19 App: The Dutch experience

Presented By
Prof. Niels Chavannes, Leiden University, the Netherlands
Conference
ERS 2020

29 October, 2020 19:57

Secondary pulmonary fibrosis: a possible long-term effect of severe COVID-19

Presented By
Prof. Francesco Blasi , University of Milan, Italy
Conference
ERS 2020

29 October, 2020 16:48

COVID-19 survivors benefit from structured follow-up

Presented By
Dr Sabina Sahanic, Medical University of Innsbruck, Austria
Conference
ERS 2020

29 October, 2020 16:35

Early pulmonary rehabilitation post-COVID-19 aids recovery

Presented By
Ms Yara Al Chikhanie, Grenoble Alps University, France
Conference
ERS 2020

29 October, 2020 15:29

Crosstalk between inflammation and coagulation in severe COVID-19 infections

Presented By
Prof. Roberta Gualtierotti, University of Milan, Italy
Conference
ISTH 2020

8 September, 2020 15:21

COVID-19 associated with higher VTE rates relative to influenza

Presented By
Dr Milou Stals, Leiden University Medical Centre, the Netherlands
Conference
ISTH 2020

8 September, 2020 15:18

Therapeutic anticoagulation not associated with lower mortality rates in COVID-19 ICU patients

Presented By
Dr Hanny Al-Samkari, Massachusetts General Hospital, USA
Trial
Cohort study
Conference
ISTH 2020

8 September, 2020 15:15

COVID-19 not associated with heightened VTE risk after discharge

Presented By
Dr Matthias Engelen, University Hospital Leuven, Belgium
Conference
ISTH 2020

8 September, 2020 15:09
site created by:   

© 2021 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy